Mader Laura B, Harris Tess, Kläger Sabine, Wilkinson Ian B, Hiemstra Thomas F
1Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
2School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Res Involv Engagem. 2018 Jul 10;4:21. doi: 10.1186/s40900-018-0104-4. eCollection 2018.
Patients usually understand their disease and lifestyle needs better than many medical professionals. They also have important ideas about what research would be most beneficial to their lives, especially on how to manage symptoms in a way that improves daily quality of life. In the UK, the National Institute for Health Research has recognised the value of patient insight, and now requires researchers with public funding to involve patients and the public throughout the research process. There are many opportunities for involvement, but these generally focus on improving study design to ensure the trial is acceptable to participants. Some programmes work towards setting research priorities as important to patients, public members, and medical experts, but due to the complexity and cost involved in running clinical trials, the majority of research originates with the pharmaceutical industry or academic institutions. There is a clear mismatch between research ideas that patients prioritise (quality of life), and those actually investigated (drug development).The Patient Led Research Hub (PLRH) is a new initiative hosted by the Cambridge Clinical Trials Unit. The PLRH supports research ideas as proposed by patient organisations, providing resources and expertise in research design and delivery. The PLRH aims to co-produce any technically feasible project, regardless of disease or symptom focus. The proposing patient group maintains ownership of the project with an active role in study management. This method of research has proven to produce credible research studies that are of direct relevance to patients.
Patient and Public Involvement has become an indispensable and expected component of healthcare research in the United Kingdom, largely driven by the National Institute of Health Research and other research funders. Opportunities for patients to become involved in research abound, and many organisations now have dedicated 'public involvement' teams. However, its value is often questioned amidst criticism of tokenism and the recognition that a mismatch persists between patient priorities and funded research. Although patients are frequently consulted, evidence that their involvement influences the research agenda remains limited. We propose a novel model that allows patients and the public not only to propose research questions, but to design, initiate and deliver their own research with all the necessary support from research professionals. We demonstrate the feasibility and utility of this approach in reporting the establishment, experiences and progress of the Patient Led Research Hub. Using this resource, patient organisations are now able to initiate and conduct rigorous clinical research unfettered by the constraints of academic or economic agendas.
患者通常比许多医学专业人员更了解自己的疾病和生活方式需求。他们对于什么样的研究对自己的生活最有益也有重要的想法,尤其是在如何以改善日常生活质量的方式管理症状方面。在英国,国家卫生研究院已经认识到患者见解的价值,现在要求获得公共资金的研究人员在整个研究过程中让患者和公众参与进来。参与的机会有很多,但这些通常集中在改进研究设计以确保试验为参与者所接受。一些项目致力于将确定研究重点作为对患者、公众成员和医学专家都很重要的事情,但由于开展临床试验涉及的复杂性和成本,大多数研究都源于制药行业或学术机构。患者优先考虑的研究想法(生活质量)与实际研究的想法(药物开发)之间存在明显的不匹配。患者主导研究中心(PLRH)是由剑桥临床试验单位主办的一项新举措。PLRH支持患者组织提出的研究想法,在研究设计和实施方面提供资源和专业知识。PLRH旨在共同开展任何技术上可行的项目,无论其关注的疾病或症状是什么。提出想法的患者群体保留项目的所有权,并在研究管理中发挥积极作用。这种研究方法已被证明能产生与患者直接相关的可靠研究。
患者和公众参与已成为英国医疗保健研究中不可或缺且预期的组成部分,这在很大程度上是由国家卫生研究院和其他研究资助者推动的。患者参与研究的机会很多,现在许多组织都有专门的“公众参与”团队。然而,在对形式主义的批评以及认识到患者优先事项与资助研究之间仍然存在不匹配的情况下,其价值常常受到质疑。尽管经常征求患者的意见,但他们的参与影响研究议程的证据仍然有限。我们提出了一种新颖的模式,该模式不仅允许患者和公众提出研究问题,还能在研究专业人员的所有必要支持下设计、发起和开展他们自己的研究。我们在报告患者主导研究中心的设立、经验和进展时展示了这种方法的可行性和实用性。利用这一资源,患者组织现在能够不受学术或经济议程的限制,发起并开展严谨的临床研究。